EUVIMEDEUVIMED entdecken
Crossref

Methyl Palmitate Modulated NMDA-Induced Cerebral Hyperemia in Hypertensive Rats

Chun-Kai Hsu, Shang-Jen Chang, Li-Yi Lim, Hsi-Hsien Chang, Stephen Shei-Dei Yang

Journal of Vascular Research · 2023

DOI: 10.1159/000529916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Research, 2023. Verfasst von Chun-Kai Hsu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, New Taipei, Taiwan. Hauptthemen laut MEDLINE: Hyperemia, Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-methyl-D-aspartate (NMDA) receptors were found to be dysfunctional in hypertensive rats. Methyl palmitate (MP) has been shown to diminish the nicotine-induced increase in blood flow in the brainstem. The aim of this study was to determine how MP modulated NMDA-induced increased regional cerebral blood flow (rCBF) in normotensive (WKY), spontaneously hypertensive (SHR), and renovascular hypertensive (RHR) rats. The increase in rCBF after the topical application of experimental drugs was measured using laser Doppler flowmetry. Topical NMDA application induced an MK-801-sensitive increase in rCBF in anesthetized WKY rats, which was inhibited by MP pretreatments. This inhibition was prevented by pretreatment with chelerythrine (a PKC inhibitor). The NMDA-induced increase in rCBF was also inhibited by the PKC activator in a concentration-dependent manner. Neither MP nor MK-801 affected the increase in rCBF induced by the topical application of acetylcholine or sodium nitroprusside. Topical application of MP to the parietal cortex of SHRs, on the other hand, increased basal rCBF slightly but significantly. MP enhanced the NMDA-induced increase in rCBF in SHRs and RHRs. These results suggested that MP had a dual effect on the modulation of rCBF. MP appears to play a significant physiological role in CBF regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperemiaHypertensionRatsAnimalsN-MethylaspartateRats, Inbred WKYRats, Inbred SHRDizocilpine MaleateReceptors, N-Methyl-D-AspartatePalmitates

Stichwörter der Autor:innen

Cerebral blood flowMethyl palmitateN-methyl-D-aspartateProtein kinase C

Substanzen

N-MethylaspartateDizocilpine MaleateReceptors, N-Methyl-D-Aspartatemethyl palmitatePalmitates

Autor:innen und Institutionen

  • Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, New Taipei, Taiwan.
  • School of Medicine, Tzu Chi University, Hualien, Taiwan.
  • Department of Surgery, Hospital Canselor Tuanku Muhriz UKM, Kuala Lumpur, Malaysia.
  • Taipei Tzu Chi Hospital, Buddhist Medical Foundation, New Taipei, Taiwan.

Zitieren

APA

Hsu, C. K., Chang, S. J., Lim, L. Y., Chang, H. H., & Shei-Dei Yang, S. (2023). Methyl Palmitate Modulated NMDA-Induced Cerebral Hyperemia in Hypertensive Rats. Journal of Vascular Research. https://doi.org/10.1159/000529916

Vancouver

Hsu CK, Chang SJ, Lim LY, Chang HH, Shei-Dei Yang S. Methyl Palmitate Modulated NMDA-Induced Cerebral Hyperemia in Hypertensive Rats. Journal of Vascular Research. 2023. doi:10.1159/000529916

BibTeX
@article{Hsu2023,
  author = {Hsu, Chun-Kai and Chang, Shang-Jen and Lim, Li-Yi and Chang, Hsi-Hsien and Shei-Dei Yang, Stephen},
  title = {Methyl Palmitate Modulated NMDA-Induced Cerebral Hyperemia in Hypertensive Rats},
  journal = {Journal of Vascular Research},
  year = {2023},
  doi = {10.1159/000529916}
}
Kostenlos starten →